Incretin receptor agonist
Tirzepatide
Tirzepatide
A dual GIP and GLP-1 receptor agonist investigated and used in regulated pharmaceutical settings.
Research specification
60 mg per vial
Private quote available
For Research Purposes Only
Request a QuoteProduct research overview
Evidence for approved pharmaceutical formulations should not be extrapolated to unverified research vials.